Latest Competition News

Big River Industries reported a 2.3% revenue decline for FY25 amid tough market conditions but achieved a notable rebound in the second half, driven by operational efficiencies and cost controls. The company maintains a strong balance sheet and a cautiously optimistic outlook for FY26.

Big River Industries reported a statutory net loss of $14.7 million for FY2025, driven by a $20 million impairment charge on intangible assets amid a 2.3% revenue decline. Despite the setback, the company declared a fully franked 2 cent dividend and showed signs of operational stabilization.

Austco Healthcare has reported a robust FY25 with revenues climbing 40% to $81.4 million and EBITDA jumping 62% to $13 million, driven by organic growth and strategic acquisitions.

Centrepoint Alliance has reported a robust FY25 with 13% revenue growth and a 30% increase in profit before tax, driven by organic adviser expansion, strategic acquisitions, and pioneering technology investments including AI and cybersecurity.

Austco Healthcare Limited reported a record $81.4 million in revenue for FY25, driven by organic growth and acquisitions including G&S Technologies. EBITDA jumped 62% to $13 million, reflecting strong operational leverage.

Helloworld Travel reported a 4.1% rise in profit after tax for FY25 despite an 8.7% revenue decline, driven by strong growth in Wholesale and Inbound segments and strategic investments in technology and acquisitions.

Beforepay Group Limited reported a strong FY25 with a 29% increase in net transaction margin and 14% revenue growth, driven by expanding user numbers and advances. The company continues to leverage AI-driven risk management while maintaining its ethical lending model.

Beforepay Group Limited reported a robust 74.5% increase in net profit after tax to $6.7 million for FY25, driven by growth in its core Pay Advance business, the launch of a Personal Loan product, and expansion of its AI-powered credit analytics division, Carrington Labs, in the US.

Kelsian Group reported FY25 results in line with expectations, showing revenue and earnings growth alongside a strategic review that could reshape its business focus. The company also provided FY26 EBITDA guidance and revealed plans to divest its Tourism Portfolio.

Bio-Gene Technology Limited reported a net loss of AUD 2.58 million for FY2025 while making significant strides in developing its bio-insecticides Flavocide and Qcide, securing US Department of Defense grants and expanding global partnerships.

Jumbo Interactive posted solid FY25 financial results with strong SaaS growth and stable dividends, despite a softer jackpot environment compared to the previous year. The company maintains a robust balance sheet and outlines a confident outlook for FY26.

SPC Global Holdings is transitioning its senior financing from Scottish Pacific to Commonwealth Bank, locking in $154 million in total facilities and expected to save $3 million annually in interest. This move positions the company for accelerated growth both in Australia and abroad.